[20 tickets free] you are invited to attend the 4th China Pharmaceutical R & D Innovation Summit 2019

What should I do if I want to participate in high-end meetings and industry dialogues for free? Here comes welfare 20 tickets + 10 books are free! Yaozh008 mobile phone official account (micro signal: search engine): 20 tickets free to send you, "2019 fourth China Pharmaceutical R & D Innovation Summit" invites you to attend the meeting Below the article, leave a message, message format: I want to participate in + the company name; or WeChat scan the next two-dimensional code , open the article directly, and leave a message at the bottom of the article Message format: I want to attend the meeting + company name; forward the wechat article to friends, colleagues or wechat groups, friend circles, and invite friends to like your message; after the activity, The top 20 participants with the most praise can get 1 ticket for this PDI Conference; the participants with the number of praise ranking 20-30 can get 1 big data of 40 years of Chinese pharmaceutical research and development At the end of the prize collection activity, those who rank in the top 30 in the number of likes in the message collection should add Yao Xiaozhi (wechat: 17318481750) to collect prizes for their friends When receiving the prize, if the prize is a ticket, please send "personal name" + "company name" + "contact information" + "screenshot of Jizan" to Xiaozhi, and after Xiaozhi confirms, issue the ticket to you; if the prize is "big data of 40 years of Chinese pharmaceutical research and development", please send "Personal name" + "company name" + "contact information" + "screenshot of Jizan" + "mailing address" will be sent to yaoxiaozhi, and will be mailed after confirmation Warm tip: readers participating in the complimentary tickets should not sign up for the summit before this time; for example, the top three readers are readers of the same company, only one reader with the highest number of likes will be given a complimentary ticket; if the user who gets the complimentary ticket gives up, the complimentary ticket will be extended to the next user with the highest number of likes; the gift for the collective praise is until June 20; the final interpretation right of this activity belongs to yaozhi.com In recent years, the two vote system, the cancellation of drug addition, "4 + 7" volume purchase, and the release of the new version of the base drug catalog A series of new policies have been issued in the pharmaceutical industry, which has brought a lot of shocks to the pharmaceutical industry In this era of both opportunities and challenges, how to play their own advantages, determine and implement the strategic plan, and improve the core competitiveness of enterprises are the issues that every pharmaceutical enterprise must consider and face The degree of solving these problems will directly determine whether the enterprise can occupy a place in the future competition of the industry In order to facilitate the decision makers of pharmaceutical enterprises and colleagues in the industry to correctly understand and accurately grasp the current trend of relevant policies and regulations in the pharmaceutical industry, grasp the current trend, seize the opportunities and meet the challenges To this end, the 4th "China Pharmaceutical R & D and Innovation Summit" in 2019, jointly sponsored by yaozhi.com, Xinhua health think tank, Southwest University, Chongqing Institute of traditional Chinese medicine, Chongqing Medical Insurance Research Association and other authoritative institutions, will be held in Chongqing International Convention and Exhibition Center (Nanping) from June 20 to 22 The meeting conducted in-depth analysis and Discussion on the theme of "strategic choice and project approval of enterprises under the new policy" The speakers included leaders and experts from medical insurance, drug supervision system and other pharmaceutical related regulatory fields, as well as executives and industry elites engaged in strategic management planning, project approval, investment evaluation and transaction of innovative drugs or generic drugs They can be described as the gathering of talents and celebrities Through various theme forums, closed door meetings, round tables and other communication platforms held by the conference organizers, the speakers will closely follow current hot topics such as R & D policies and trends in the pharmaceutical industry, strategic choice of enterprises, project selection and project approval, project evaluation and transaction, and carry out extensive in-depth discussion and exchange with all participants to answer questions and solve doubts I hope we can make an appointment with gilding in June and get together in this industry grand meeting! [conference overview] time: June 20-22, 2019 location: Chongqing International Conference and Exhibition Center (Nanping), guiding unit: China Pharmaceutical University, China Pharmaceutical Enterprise Management Association, Chongqing pharmaceutical association, Chongqing Economic and information technology committee, Chongqing Economic and Technological Development Zone Management Committee, Chongqing Nan'an District People's government sponsor, yaozhi.com, Xinhua health think tank, Southwest University Chongqing Institute of traditional Chinese medicine, Chongqing Medical Insurance Research Association undertaker Kangzhou big data research institute, Institute of pharmaceutical intelligence, organization collection Co organizer Shanghai Huyuan Pharmaceutical Co., Ltd supporter Nanjing Huawei Pharmaceutical Technology Group Co., Ltd media support of Chongqing Nan'an District Pharmaceutical Industry Association Xinhuanet.com, chbd.com, medicine guide, aoya.com, Sina medicine, tongshuyi.com, medicine era, Biovalley, biological exploration, pharmaceutical circle, shell agency, huiyao.com, huiyao.com, nantong.com, pharmaceutical research, pharmaceutical industry, Peiyou innovation, crou pharmaceutical online, CPHI pharmaceutical online, YanRuYu, pharmaceutical research and development, aimida Industrial Research [meeting agenda] June 21 [meeting expenses] ● the meeting expenses have included the lunch and dinner expenses of participants during the meeting from June 21 to 22 ● in order to ensure the smooth holding of the conference, the conference will not accept the on-site payment; ● payment method: the application fee will be received by bank wire transfer and post office remittance; ● conference fee consultation: Cheng Huizhu 13883622335 ● collection information: Account Name: Chongqing Kangzhou big data Co., Ltd account number: 310003011910096622 account bank: Chongqing Chayuan branch of industrial and Commercial Bank of China [contact person for the conference] [registration method] 1 Scan the QR code below to sign up for the conference ~ ~ 2 Click the link directly to sign up for the conference: http://f86dij8j8497bi88.mikecrm.com/jnczqqv